Analytical methodology and the interface with animal drug approval

Area of Science:

• Veterinary Medicine
• Drug Safety
• Regulatory Science

Background:

• The U.S. Food and Drug Administration (FDA) is responsible for ensuring the safety of approved animal drugs.
• Post-market surveillance and periodic review are critical components of drug safety assurance.
• Evolving scientific understanding and data may necessitate re-evaluation of previously approved products.

Purpose of the Study:

• To systematically review currently approved animal drugs.
• To determine the need for updated safety data for approved animal drugs.
• To ensure continuing assurance of the safety of approved animal drug uses for human health.

Main Methods:

• Conducting a systematic review of the FDA's inventory of approved animal drugs.
• Prioritizing review based on the anticipated significance to human health.
• Evaluating existing safety data and identifying potential gaps.

Main Results:

• The FDA has initiated a comprehensive review process.
• The review focuses on identifying animal drugs requiring updated safety evaluations.
• Prioritization is based on potential human health impacts.

Conclusions:

• The FDA is proactively reassessing animal drug safety.
• This systematic approach aims to maintain high safety standards.
• Ensuring animal drug safety is integral to public health protection.